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Background: Histological studies have demonstrated a potential role of inflammation and neoangiogenesis in the pathogenesis of aortic valve 
stenosis (AVS), similarly to atherosclerotic lesions. Local inflammatory activation may generate heat. We therefore investigated in patients with AVS 
whether there is a concurrence of heat production, inflammation and neoangiogenesis within the valve leaflets.
Methods: We excised 96 leaflets from 32 patients during aortic valve replacement. Seventy-five leaflets were from 25 patients with AVS and 21 
from 7 patients with aortic valve insufficiency (AVI) (control group). Temperature measurements were performed before hypothermic cardioplegia. 
Temperature difference (ΔT) was assigned as the mean temperature of each leaflet minus the temperature of the aortic wall. Histological and 
immunohistological analysis for CD3-positive inflammatory cells and vascular endothelial growth factor (VEGF) immunoreactivity was performed. 
Specimens were categorized into two groups using a cut-off value of 2 based on the semiquantitative scale for CD3.
Results: Mean ΔT was greater in leaflets with intense compared with low expression of CD3 (1.26±1.11°C vs. 0.51±1.01°C). All leaflets with 
intense expression of CD3 (>3), were from specimens with AVS, whereas 67.7% (21 out of 31) specimens with low expression of CD3 were from 
control specimens (p<0.01). Mean ΔT was greater in leaflets with intense compared with low expression of VEGF (1.28±1.14°C vs. 0.18 ± 0.38°C, 
p<0.01). All leaflets with intense expression of VEGF (>4), were from specimens with AVS, whereas 29.1% (7 out of 24) specimens with low expression 
of VEGF were from control specimens (p<0.01). When we analysed leaflets of patients with AVS, 89.3% (67 out of 75) had intense expression of CD3 
(>3), whereas only 10.6% (8 out of 75) had low expression of CD3 (p<0.01). In leaflets of patients with AVS, 95.5% (n=64 out of 67) of leaflets with 
high CD3, had intense expression of VEGF (>4).
Conclusions: Neoangiogenesis and local inflammatory activation concur in the leaflets of patients with AVS. Future studies need to be performed 
to investigate possible prognostic and therapeutic implications.
